Chemo-
photothermal therapy (chemo-PTT) mediated by nanomaterials holds a great potential for
cancer treatment. However, the
tumor uptake of the systemically administered nanomaterials was recently found to be below 1%. To address this limitation, the development of
injectable tridimensional polymeric matrices capable of delivering nanomaterials directly into the
tumor site appears to be a promising approach. In this work, an
injectable in situ forming ionotropically crosslinked
chitosan-based
hydrogel co-incorporating IR780 loaded nanoparticles (IR/BPN) and
Doxorubicin (DOX) loaded nanoparticles (DOX/TPN) was developed for application in
breast cancer chemo-PTT. The produced
hydrogels (IR/BPN@Gel and IR/BPN+DOX/TPN@Gel) displayed suitable physicochemical properties and produced a temperature increase of about 9.1 °C upon exposure to Near Infrared (NIR) light. As importantly, the NIR-light exposure also increased the release of DOX from the
hydrogel by 1.7-times. In the in vitro studies, the combination of IR/BPN@Gel with NIR light (
photothermal therapy) led to a reduction in the viability of
breast cancer cells to 35%. On the other hand, the non-irradiated IR/BPN+DOX/TPN@Gel (
chemotherapy) only diminished
cancer cells' viability to 85%. In contrast, the combined action of IR/BPN+DOX/TPN@Gel and NIR light reduced
cancer cells' viability to about 9%, demonstrating its potential for
breast cancer chemo-PTT.